Webinars

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Oncology
Print
Sponsored

Clinical decision-making insights for haem/oncs

Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Debates & Insight
QuintilesIMS Webinar 529118513 2017 16x9_Img4
Sponsored

Improving Outcomes Through Industry Partnership - Learnings ...

A unique example of partnership working across the health system, focusses on the service at large, not just the pill, and uses leading-edge data analytics to analyse, benchmark and visualise the current state of the cancer pathways within the Cancer Vanguard Trusts. Furthermore, it encompasses multiple aspects of the service provision ranging from patient outcomes and experiences, the flow of treatment and the usage of medicine in order to inform an evidence-based and patient-centric approach to service redesign and resource optimisation.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Debates & Insight
QuintilesIMS Rare Diseases webinar _16x9 holding slide_170405
Sponsored

When small becomes big: orphan medicines, advances, access a...

Significant unmet need still remains in the rare disease market, only around 5% of rare diseases currently have an approved drug treatment. This represents a major opportunity for the pharmaceutical industry. Our webinar will assess the critical factors underpinning success in the rare disease space and provide a view into the future of market access and health technology assessments for orphan medicines – alongside the impact on R&D and clinical trials – in the context of Brexit negotiations.